Influence of government price regulation and deregulation on the price of antineoplastic medications in China: a controlled interrupted time series study

BACKGROUND: In October 2012, the Chinese government established maximum retail prices for specific products, including 30 antineoplastic medications. Three years later, in June 2015, the government abolished price regulation for most medications, including all antineoplastic medications. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Xiaodong, Wushouer, Haishaerjiang, Yang, Mingchun, Han, Sheng, Shi, Luwen, Ross-Degnan, Dennis, Wagner, Anita Katharina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Health Policy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924745/
https://www.ncbi.nlm.nih.gov/pubmed/31784440
http://dx.doi.org/10.1136/bmjopen-2019-031658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924745/
https://www.ncbi.nlm.nih.gov/pubmed/31784440
http://dx.doi.org/10.1136/bmjopen-2019-031658

Ejemplares similares